A peptide nucleic acid, or PNA, is a synthetic nucleic-acid analog whose bases are attached to an uncharged peptide-like backbone instead of the sugar-phosphate chain found in DNA and RNA. First reported in the 1980s, it is often described as a third-generation antisense agent. Because the backbone carries no charge, a PNA strand does not repel the negatively charged phosphate backbone of a target nucleic acid, so its pairing with DNA or RNA is both more stable and more specific than the natural interaction. PNA is also resistant to the nucleases and proteases that degrade normal nucleic acids and peptides, which makes it unusually stable in both cellular and cell-free environments. A custom PNA synthesis service produces these molecules to order, with or without labels, and supports the project from sequence design through a characterized final product.
Figure 1. PNAs hybridize to complementary DNA by hydrogen bonding. (Source: Wu JC, et al. 2017)
The uncharged, high-affinity nature of PNA gives it several binding modes that are difficult for ordinary oligos to achieve, and which are what make it useful as a research and diagnostic tool.
PNA is used wherever a probe or inhibitor must bind DNA or RNA with high stability and specificity. Common uses include antisense and gene-expression studies, the detection and capture of specific sequences in diagnostics, sequence-specific molecular tools such as biosensors, antimicrobial and anti-pest research, and any assay that benefits from a nuclease-resistant, high-affinity capture strand.
The same synthesis platform supports both plain and modified molecules, and the choice is made on what the experiment needs.
Unlabeled PNA synthesis. Plain PNA is synthesized to the requested length and quantity, purified, and delivered with the characterization needed to confirm identity and purity. This is the right choice when the molecule is used internally or captured indirectly.
Labeled and modified PNA synthesis. A broad set of fluorescent and quencher dyes can be attached for direct detection, and a range of functional groups is available — amines, thiols, azides, acetylated and maleimide ends, and biotin for affinity capture — together with linker spacers and backbone modifications such as gamma and alpha variants that improve solubility and binding. The label and modification are selected to match the readout and conjugation chemistry of the assay.
Good results depend on a design that the molecule can actually form, and several practical rules are applied during the design check.
A project begins when the customer supplies the target sequence and the requirements — length, quantity, purity, and any label or modification. The design is reviewed against the rules above, and where a sequence is likely to misbehave the issue is raised before any synthesis is committed. The molecule is then synthesized and purified, checked by purity analysis and mass spectrometry, and delivered with a report covering both. Scales run from the low nanomole range up to milligram amounts, and typical turnaround is a few weeks depending on length, modification, and quantity.
Reference